Abstract
Propranolol has been available to clinical medicine for over a decade. It was used initially in the treatment of tachyarrhythmias and angina pectoris but now has much more widespread application. Recently the drug is being used more frequently in the treatment of hypertension, and its indications are discussed.
The metabolism and clearance in the liver has major effects on the serum level. With improved knowledge of the properties and adverse effects of this potent agent, it is now possible to apply better patient selection.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alderman E. L., Coltart D. J., Wettach G. E., Harrison D. C. Coronary artery syndromes after sudden propranolol withdrawal. Ann Intern Med. 1974 Nov;81(5):625–627. doi: 10.7326/0003-4819-81-5-625. [DOI] [PubMed] [Google Scholar]
- Alderman E. L., Davies R. O., Crowley J. J., Lopes M. G., Brooker J. Z., Friedman J. P., Graham A. F., Matlof H. J., Harrison D. C. Dose response effectiveness of propranolol for the treatment of angina pectoris. Circulation. 1975 Jun;51(6):964–975. doi: 10.1161/01.cir.51.6.964. [DOI] [PubMed] [Google Scholar]
- Coltart D. J., Shand D. G. Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man. Br Med J. 1970 Sep 26;3(5725):731–734. doi: 10.1136/bmj.3.5725.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Evans G. H., Shand D. G. Disposition of propranolol. VI. Independent variation in steady-state circulating drug concentrations and half-life as a result of plasma drug binding in man. Clin Pharmacol Ther. 1973 Jul-Aug;14(4):494–500. doi: 10.1002/cpt1973144part1494. [DOI] [PubMed] [Google Scholar]
- Gibson D. G. Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man. Drugs. 1974;7(1):8–38. doi: 10.2165/00003495-197407010-00002. [DOI] [PubMed] [Google Scholar]
- Grant R. H., Keelan P., Kernohan R. J., Leonard J. C., Nancekievill L., Sinclair K. Multicenter trial of propranolol in angina pectoris. Am J Cardiol. 1966 Sep;18(3):361–365. doi: 10.1016/0002-9149(66)90054-3. [DOI] [PubMed] [Google Scholar]
- PRICHARD B. N., GILLAM P. M. USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION. Br Med J. 1964 Sep 19;2(5411):725–727. doi: 10.1136/bmj.2.5411.725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Prichard B. N. Beta-adrenergic receptor blocking drugs in angina pectoris. Drugs. 1974;7(1):55–84. doi: 10.2165/00003495-197407010-00005. [DOI] [PubMed] [Google Scholar]
- Shand D. G., Nuckolls E. M., Oates J. A. Plasma propranolol levels in adults with observations in four children. Clin Pharmacol Ther. 1970 Jan-Feb;11(1):112–120. doi: 10.1002/cpt1970111112. [DOI] [PubMed] [Google Scholar]
- Tyrer P. J., Lader M. H. Response to propranolol and diazepam in somatic and psychic anxiety. Br Med J. 1974 Apr 6;2(5909):14–16. doi: 10.1136/bmj.2.5909.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zacharias F. J., Cowen K. J., Prestt J., Vickers J., Wall B. G. Propranolol in hypertension: a study of long-term therapy, 1964-1970. Am Heart J. 1972 Jun;83(6):755–761. doi: 10.1016/0002-8703(72)90206-2. [DOI] [PubMed] [Google Scholar]